Belser Jessica A, Pulit-Penaloza Joanna A, Brock Nicole, Sun Xiangjie, Kieran Troy J, Pappas Claudia, Zeng Hui, Vu Michelle N, Lakdawala Seema S, Tumpey Terrence M, Maines Taronna R
Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Lancet Microbe. 2025 Jul;6(7):101070. doi: 10.1016/j.lanmic.2024.101070. Epub 2025 Mar 17.
The human eye represents a potential site of influenza A virus (IAV) replication, and an entry point for the virus to reach the respiratory tract. The frequent detection of conjunctivitis among farm workers with confirmed infection with clade 2.3.4.4b A(H5N1) IAV from this ongoing outbreak represents an atypical disease presentation for this virus subtype. We aimed to investigate whether the occurrence of ocular complications reported following clade 2.3.4.4b A(H5N1) virus infection was associated with an enhanced capacity of this virus to replicate in mammalian ocular tissue and cause infection following ocular exposure.
Primary human nasal and corneal tissue constructs were infected with A(H5N1) A/Texas/37/2024 (Texas/37), A(H1N1)pdm09 A/Nebraska/14/2019 (Neb/14), and A(H7N7) A/Netherlands/219/2003 (NL/219) viruses (multiplicity of infection [MOI] of 0·01-0·02, 33°C). Corneal tissue constructs were also infected with an expanded panel of IAVs (Texas/37, A[H5N1] A/Michigan/90/2024 [MI/90], A[H5N1] A/Chile/25945/2023 [Chile/25945], NL/219, A/Netherlands/230/2003 [NL/230], and Neb/14; MOI of 0·01, 37°C). In-vitro infections of tissue constructs were used to assess replication kinetics by infectious virus titration. Induction of innate host antiviral responses in infected corneal tissue constructs was assessed by PCR array (MOI of 2·00, 37°C). Ferrets (serologically naive or pre-immune to A[H1N1]pdm09 virus) were inoculated by the ocular route with Texas/37 A(H5N1) virus-using a liquid inoculum (10⁶ plaque forming units [PFU]), aerosol inhalation (15-16 PFU), or ocular-only aerosol exposure (18-132 PFU)-to assess pathogenicity and tropism of the virus following different exposure routes. Transmissibility was assessed by placing serologically naive or pre-immune ferrets inoculated by ocular-only aerosol exposure in direct contact with serologically naive ferrets, monitoring pathogenicity in contact animals, and measuring viral titres in nasal washes of both inoculated and contact ferrets.
Nasal and corneal tissue constructs supported replication of all IAVs tested. In corneal tissue constructs, A(H7N7) and A(H1N1)pdm09 viruses reached 10-fold higher overall titres than A(H5N1) isolates. Relatively few genes (n=13) related to antiviral responses were significantly differentially expressed in corneal tissue constructs infected with IAV, with no consistent differential expression among clade 2.3.4.4b A(H5N1) viruses associated with either conjunctivitis or severe respiratory disease, although strain-specific differences were observed. Serologically naive ferrets inoculated by liquid ocular, aerosol inhalation, or aerosol-only ocular routes with Texas/37 virus exhibited a systemic and fatal infection in all animals, transmitting the virus to naive cagemates. By contrast, reduced disease severity following ocular-only aerosol inoculation was observed in animals with pre-existing heterosubtypic immunity. No serologically naive ferrets placed in direct contact with pre-immune ferrets inoculated with Texas/37 virus by the ocular-only aerosol route became infected.
A clade 2.3.4.4b A(H5N1) virus from the dairy cattle outbreak in the USA that was first detected in March, 2024, does not appear to possess features indicative of an ocular tropism. However, this virus can maintain a virulent and transmissible phenotype in ferrets following ocular exposure, highlighting the importance of ocular protection.
US Centers for Disease Control and Prevention.
人眼是甲型流感病毒(IAV)潜在的复制场所,也是该病毒进入呼吸道的入口。在此次持续爆发的疫情中,感染2.3.4.4b分支A(H5N1)IAV的农场工人中频繁检测到结膜炎,这是该病毒亚型非典型的疾病表现。我们旨在调查2.3.4.4b分支A(H5N1)病毒感染后报告的眼部并发症的发生是否与该病毒在哺乳动物眼部组织中复制并在眼部暴露后引起感染的能力增强有关。
用人鼻和角膜组织原代构建体感染A(H5N1)A/得克萨斯/37/2024(得克萨斯/37)、A(H1N1)pdm09 A/内布拉斯加/14/2019(内布/14)和A(H7N7)A/荷兰/219/2003(NL/219)病毒(感染复数[MOI]为0·01 - 0·02,33°C)。角膜组织构建体还用一组扩展的IAV进行感染(得克萨斯/37、A[H5N1]A/密歇根/90/2024[MI/90]、A[H5N1]A/智利/25945/2023[智利/25945]、NL/219、A/荷兰/230/2003[NL/230]和内布/14;MOI为0·01,37°C)。通过感染性病毒滴定,利用组织构建体的体外感染来评估复制动力学。通过PCR阵列评估感染的角膜组织构建体中宿主先天抗病毒反应的诱导情况(MOI为2·00,37°C)。用得克萨斯/37 A(H5N1)病毒通过眼内途径接种雪貂(血清学上未接触过或对A[H1N1]pdm09病毒有预免疫),使用液体接种物(10⁶ 蚀斑形成单位[PFU])、气溶胶吸入(15 - 16 PFU)或仅眼内气溶胶暴露(18 - 132 PFU),以评估不同暴露途径后病毒的致病性和嗜性。通过将仅经眼内气溶胶暴露接种的血清学上未接触过的或有预免疫的雪貂与血清学上未接触过的雪貂直接接触,监测接触动物的致病性,并测量接种和接触雪貂鼻洗液中的病毒滴度,来评估传播性。
鼻和角膜组织构建体支持所有测试IAV的复制。在角膜组织构建体中,A(H7N7)和A(H1N1)pdm09病毒的总体滴度比A(H5N1)分离株高10倍。在感染IAV的角膜组织构建体中,相对较少(n = 13)与抗病毒反应相关的基因有显著差异表达,2.3.4.4b分支A(H5N1)病毒中与结膜炎或严重呼吸道疾病相关的基因没有一致的差异表达,不过观察到了毒株特异性差异。通过液体眼内、气溶胶吸入或仅眼内气溶胶途径用得克萨斯/37病毒接种血清学上未接触过的雪貂,所有动物均出现全身性致命感染,并将病毒传播给未接触过的同笼动物。相比之下,在已有异源亚型免疫的动物中,仅眼内气溶胶接种后的疾病严重程度降低。没有血清学上未接触过的雪貂与通过仅眼内气溶胶途径接种得克萨斯/37病毒的有预免疫的雪貂直接接触而被感染。
2024年3月首次在美国奶牛疫情中检测到的一株2.3.4.4b分支A(H5N1)病毒似乎不具有指示眼嗜性的特征。然而,该病毒在眼部暴露后可在雪貂中维持毒力和可传播表型,突出了眼部防护的重要性。
美国疾病控制与预防中心。